Articles dans des revues avec comité de lecture (19)
  1. 1. Grosbois, J., Bisteau, X., Imbault, V., Conrard, L., Condorelli, M., Findikli, N., Lybaert, P., & Demeestere, I. (2025). Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage. Human reproduction, 40(12), 2395-2408. doi:10.1093/humrep/deaf203
  2. 2. Kosa, A.-C., López Gutiérrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet-Depauw, A., Pieters, K., Van Morckhoven, D., Imbault, V., Dubois, C., Bisteau, X., Stamatopoulos, B., Igoillo Esteve, M., Brion, J. P., & Leroy, K. (2025). Differential effects of age and sex on tau pathology propagation in the htau mouse model: a neuropathological and proteomic study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e70784. doi:doi.org/10.1002/alz.70784
  3. 3. Bande, M., Delporte, C., SAKIRA, A. K., Bourez, A., Imbault, V., Bisteau, X., Sombié, C., Some, T. I., & Van Antwerpen, P. (2025). Development of An Analytical Model for Assessing the Adsorptive Properties of Traditional Medicinal Formulations from Burkina Faso in Relation to Snake Venom Proteins. Toxicon, 108470. doi:10.1016/j.toxicon.2025.108470
  4. 4. Kaafarani, A., Darche-Gabinaud, R., Bisteau, X., Imbault, V., Wittamer, V., Parmentier, M., & Pirson, I. (2023). Proximity Interactome Analysis of Super Conserved Receptors Expressed in the Brain Identifies EPB41L2, SLC3A2, and LRBA as Main Partners. Cells, 12(22), 2625. doi:10.3390/cells12222625
  5. 5. Dionisi, C., Chazalon, M., Rai, M., Keime, C., Imbault, V., Communi, D., Puccio, H., Schiffmann, S. N., & Pandolfo, M. (2023). Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties. Brain Communications, 5(1), fcad007. doi:10.1093/braincomms/fcad007
  6. 6. Santacruz, C. A., Vincent, J. L., Imbault, V., Bruneau, M., Creteur, J., Brimioulle, S., Vincent, R., Communi, D., & Taccone, F. S. (2023). Cerebral apolipoprotein E and amyloid precursor-like protein 1 as risk factors for chronic neurodegeneration after non-traumatic acute brain injury (ABI). Critical care, 27(1), 249. doi:10.1186/s13054-023-04538-y
  7. 7. Santacruz, C. A., Vincent, J. L., Duitama, J., Bautista, E., Imbault, V., Bruneau, M., Creteur, J., Brimioulle, S., Communi, D., & Taccone, F. S. (2023). vCSF Danger-associated Molecular Patterns After Traumatic and Nontraumatic Acute Brain Injury: A Prospective Study. Journal of neurosurgical anesthesiology. doi:10.1097/ANA.0000000000000916
  8. 8. Rovira I Berger, M., Miserocchi, M., Montanari, A., Hammou, L., Chomette, L., Pozo Gomez, J., Imbault, V., Bisteau, X., & Wittamer, V. (2022). Zebrafish Galectin 3 binding protein is the target antigen of the microglial 4C4 monoclonal antibody. Developmental dynamics. doi:10.1002/dvdy.549
  9. 9. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2022). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology (Online), 61(7), 2826-2834. doi:10.1093/rheumatology/keab838
  10. 10. Imbault, V., Dionisi, C., Naeije, G., Communi, D., & Pandolfo, M. (2022). Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation. Frontiers in Neuroscience, 16, 885313. doi:10.3389/fnins.2022.885313
  11. 11. Santacruz, C., Vincent, J. L., Duitama, J., Bautista, E., Imbault, V., Bruneau, M., Creteur, J., Brimioulle, S., Communi, D., & Taccone, F. S. (2022). The Cerebrospinal Fluid Proteomic Response to Traumatic and Nontraumatic Acute Brain Injury: A Prospective Study. Neurocritical care. doi:10.1007/s12028-022-01507-1
  12. 12. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2021). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology. doi:10.1093/rheumatology/keab838
    13. << Précédent 1 2 Suivant >>